Robust Bayesian nonlinear mixed-effects modeling of time to positivity in tuberculosis trials

Pharmaceutical Statistics
Divan Aristo BurgerDing-Geng Chen

Abstract

Early phase 2 tuberculosis (TB) trials are conducted to characterize the early bactericidal activity (EBA) of anti-TB drugs. The EBA of anti-TB drugs has conventionally been calculated as the rate of decline in colony forming unit (CFU) count during the first 14 days of treatment. The measurement of CFU count, however, is expensive and prone to contamination. Alternatively to CFU count, time to positivity (TTP), which is a potential biomarker for long-term efficacy of anti-TB drugs, can be used to characterize EBA. The current Bayesian nonlinear mixed-effects (NLME) regression model for TTP data, however, lacks robustness to gross outliers that often are present in the data. The conventional way of handling such outliers involves their identification by visual inspection and subsequent exclusion from the analysis. However, this process can be questioned because of its subjective nature. For this reason, we fitted robust versions of the Bayesian nonlinear mixed-effects regression model to a wide range of TTP datasets. The performance of the explored models was assessed through model comparison statistics and a simulation study. We conclude that fitting a robust model to TTP data obviates the need for explicit identification and ...Continue Reading

References

Jul 15, 2006·The Journal of Antimicrobial Chemotherapy·D A Mitchison
Feb 28, 2009·The Lancet Infectious Diseases·Robert S WallisAlimuddin Zumla
Jul 25, 2009·Statistics in Medicine·David LunnNicky Best
May 26, 2010·Antimicrobial Agents and Chemotherapy·Andreas H DiaconMelvin K Spigelman
Aug 20, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A H DiaconP R Donald
Mar 21, 2012·Antimicrobial Agents and Chemotherapy·Andreas H DiaconMelvin K Spigelman
Oct 10, 2013·Pharmaceutical Statistics·Rolando De la Cruz
Oct 16, 2013·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·C M BarkJ L Johnson
Oct 17, 2014·Journal of Biopharmaceutical Statistics·Divan Aristo Burger, Robert Schall
Jan 27, 2015·American Journal of Respiratory and Critical Care Medicine·Andreas H DiaconCarl M Mendel
Sep 30, 2017·The Journal of Antimicrobial Chemotherapy·Elin M Svensson, Mats O Karlsson

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.